International Stem Cell Corp., a California-based biotechnology company specializing in the therapeutic applications of human parthenogenetic stem cells (hpSCs), just announced that amendments have been made to its license agreements with Advanced Cell Technology, Inc. First entered into in 2004, the license agreements provide access to an array of patents and patent applications for the [...]